You have 9 free searches left this month | for more free features.

City

Beijing (1)

Philadelphia (1)

Condition

Bacterial Pneumonia (1)

Healthy Subjects (1)

Hematopoietic Stem Cell Transplantation (1)

Neutropenia (1)

Overall Status

Completed (2)

Unknown status (1)

Sign in for free

Phase

n/a (1)

phase 1 (1)

phase 3 (1)

Sponsor

Chinese PLA General Hospital (1)

Merck Sharp & Dohme LLC (1)

Wyeth is now a wholly owned subsidiary of Pfizer (1)

Collaborator

Intervention

piperacillin (3)

bli-489 (1)

bli-489/piperacillin (1)

cilastatin (1)

imipenem (1)

linezolid (1)

piperacillin-tazobactam combination product (1)

relebactam (1)

tazobactam (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

piperacillin

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Bacterial Pneumonia Trial (Imipenem, Relebactam, Cilastatin)

Completed

Has Results

Bacterial Pneumonia

Imipenem
+5 more

(no location specified)

Apr 3, 2020

Neutropenia, Hematopoietic Stem Cell Transplantation Trial in Beijing (Piperacillin, Piperacillin-tazobactam combination

Unknown status

Neutropenia
Hematopoietic Stem Cell Transplantation

Piperacillin
Piperacillin-tazobactam combination product

Beijing, Beijing, China

Chinese PLA general hospital

Oct 25, 2012

Healthy Subjects Trial in Philadelphia (BLI-489/Piperacillin, BLI-489, Piperacillin)

Completed

Healthy Subjects

BLI-489/Piperacillin
+2 more

Philadelphia, Pennsylvania

(unnamed)

Jul 16, 2009